Imricor is trying to bring heart rhythm procedures into the MRI room, and an aging population could mean more patients who need this kind of care. The upside depends on hospitals adopting a newer way of working and key U.S. approvals arriving on time, while today’s small sales and ongoing losses make delays especially risky.Read more
Imricor is betting that doing heart rhythm procedures inside an MRI room can make treatment safer and more effective, which could open the door to many more patients and hospitals. The big question is whether regulators and hospitals move fast enough before ongoing losses and heavy spending force difficult funding choices.Read more
Imricor is trying to bring heart rhythm treatment into MRI rooms, but the big question is whether hospitals adopt it fast enough and whether US approvals arrive on time. If those pieces fall into place, interest from hospitals and new clinical results could turn today’s losses into a much stronger business.Read more
No trending discussion available.
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
